Kristen M. Oelschlager serves as the Chief Operating Officer at Castle Biosciences, Inc., a role she has held since joining the company in 2017. With a robust background in the life sciences and diagnostics industries, Kristen has been instrumental in driving the company's operational strategy and growth. Prior to Castle Biosciences, she held various leadership positions at notable companies such as Affymetrix, where she served as Vice President of Global Operations, and Life Technologies, where she was Senior Director of Global Operations. Her extensive experience in operations and strategic planning has been pivotal in scaling Castle Biosciences’ capabilities and enhancing its market presence. At Castle Biosciences, Kristen oversees the company's operational activities, including manufacturing, quality assurance, and supply chain management. Under her leadership, the company has successfully expanded its diagnostic test offerings and improved its operational efficiency, contributing significantly to Castle Biosciences' mission of improving patient care through innovative diagnostic solutions. Kristen's strategic vision has been crucial in navigating the complexities of the diagnostics market, ensuring that the company remains at the forefront of technological advancements and regulatory compliance. Kristen holds a Bachelor of Science degree in Chemical Engineering from the University of California, Santa Barbara, and an MBA from Santa Clara University. Her educational background, combined with her professional achievements, has equipped her with the skills necessary to lead Castle Biosciences through its next phase of growth. Kristen's dedication to excellence and her ability to foster a culture of innovation have solidified her reputation as a key leader in the diagnostics industry.